Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Capecitabine API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Capecitabine API market segmented into
Purity ? 98 %
Purity ? 99 %
Based on the end-use, the global Capecitabine API market classified into
Capecitabine Tablets
Others
Based on geography, the global Capecitabine API market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Apotex Pharmachem
Aarti Industries
Scion Pharm Taiwan
Shilpa Medicare Limited
Qilu Pharmaceutial
Dr. Reddy's Laboratories
Haizhou Pharma
Acebright
Gland Chemicals
Cipla
Xinxiang Tuoxin Pharmaceutical
Xinxiang Best Pharmaceutical
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CAPECITABINE API INDUSTRY
2.1 Summary about Capecitabine API Industry
2.2 Capecitabine API Market Trends
2.2.1 Capecitabine API Production & Consumption Trends
2.2.2 Capecitabine API Demand Structure Trends
2.3 Capecitabine API Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Purity ? 98 %
4.2.2 Purity ? 99 %
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Capecitabine Tablets
4.3.2 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Purity ? 98 %
5.2.2 Purity ? 99 %
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Capecitabine Tablets
5.3.2 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Purity ? 98 %
6.2.2 Purity ? 99 %
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Capecitabine Tablets
6.3.2 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Purity ? 98 %
7.2.2 Purity ? 99 %
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Capecitabine Tablets
7.3.2 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Purity ? 98 %
8.2.2 Purity ? 99 %
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Capecitabine Tablets
8.3.2 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Purity ? 98 %
9.2.2 Purity ? 99 %
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Capecitabine Tablets
9.3.2 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Apotex Pharmachem
10.1.2 Aarti Industries
10.1.3 Scion Pharm Taiwan
10.1.4 Shilpa Medicare Limited
10.1.5 Qilu Pharmaceutial
10.1.6 Dr. Reddy's Laboratories
10.1.7 Haizhou Pharma
10.1.8 Acebright
10.1.9 Gland Chemicals
10.1.10 Cipla
10.1.11 Xinxiang Tuoxin Pharmaceutical
10.1.12 Xinxiang Best Pharmaceutical
10.2 Capecitabine API Sales Date of Major Players (2017-2020e)
10.2.1 Apotex Pharmachem
10.2.2 Aarti Industries
10.2.3 Scion Pharm Taiwan
10.2.4 Shilpa Medicare Limited
10.2.5 Qilu Pharmaceutial
10.2.6 Dr. Reddy's Laboratories
10.2.7 Haizhou Pharma
10.2.8 Acebright
10.2.9 Gland Chemicals
10.2.10 Cipla
10.2.11 Xinxiang Tuoxin Pharmaceutical
10.2.12 Xinxiang Best Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Capecitabine API Product Type Overview
2.Table Capecitabine API Product Type Market Share List
3.Table Capecitabine API Product Type of Major Players
4.Table Brief Introduction of Apotex Pharmachem
5.Table Brief Introduction of Aarti Industries
6.Table Brief Introduction of Scion Pharm Taiwan
7.Table Brief Introduction of Shilpa Medicare Limited
8.Table Brief Introduction of Qilu Pharmaceutial
9.Table Brief Introduction of Dr. Reddy's Laboratories
10.Table Brief Introduction of Haizhou Pharma
11.Table Brief Introduction of Acebright
12.Table Brief Introduction of Gland Chemicals
13.Table Brief Introduction of Cipla
14.Table Brief Introduction of Xinxiang Tuoxin Pharmaceutical
15.Table Brief Introduction of Xinxiang Best Pharmaceutical
16.Table Products & Services of Apotex Pharmachem
17.Table Products & Services of Aarti Industries
18.Table Products & Services of Scion Pharm Taiwan
19.Table Products & Services of Shilpa Medicare Limited
20.Table Products & Services of Qilu Pharmaceutial
21.Table Products & Services of Dr. Reddy's Laboratories
22.Table Products & Services of Haizhou Pharma
23.Table Products & Services of Acebright
24.Table Products & Services of Gland Chemicals
25.Table Products & Services of Cipla
26.Table Products & Services of Xinxiang Tuoxin Pharmaceutical
27.Table Products & Services of Xinxiang Best Pharmaceutical
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Capecitabine API Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Capecitabine API Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Capecitabine API Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Capecitabine API Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Capecitabine API Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Capecitabine API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Capecitabine API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Capecitabine API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Capecitabine API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Capecitabine API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Capecitabine API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Capecitabine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Capecitabine API Sales Revenue (Million USD) of Apotex Pharmachem 2017-2020e
60.Figure Capecitabine API Sales Revenue (Million USD) of Aarti Industries 2017-2020e
61.Figure Capecitabine API Sales Revenue (Million USD) of Scion Pharm Taiwan 2017-2020e
62.Figure Capecitabine API Sales Revenue (Million USD) of Shilpa Medicare Limited 2017-2020e
63.Figure Capecitabine API Sales Revenue (Million USD) of Qilu Pharmaceutial 2017-2020e
64.Figure Capecitabine API Sales Revenue (Million USD) of Dr. Reddy's Laboratories 2017-2020e
65.Figure Capecitabine API Sales Revenue (Million USD) of Haizhou Pharma 2017-2020e
66.Figure Capecitabine API Sales Revenue (Million USD) of Acebright 2017-2020e
67.Figure Capecitabine API Sales Revenue (Million USD) of Gland Chemicals 2017-2020e
68.Figure Capecitabine API Sales Revenue (Million USD) of Cipla 2017-2020e
69.Figure Capecitabine API Sales Revenue (Million USD) of Xinxiang Tuoxin Pharmaceutical 2017-2020e
70.Figure Capecitabine API Sales Revenue (Million USD) of Xinxiang Best Pharmaceutical 2017-2020e
71.
